In a landmark study demonstrating “proof of principle” of the feasibility and safety of “slowing or turning back the clock,” Spanish researchers gave aged mice a single treatment to stimulate genetic expression of telomerase that extended health and lifespan by up to 24 percent.
These new results serve as yet more validation of research performed by Isagenix Founder John Anderson in partnership with molecular biologist Bill Andrews, Ph.D., on inducing the expression of telomerase in humans with natural compounds for healthier aging and greater longevity. This research is what led to the creation of Isagenix product, Product B.
Although previous research has long suggested telomerase expression would maximize the potential for cells to replicate, Maria Blasco, Ph.D., and fellow researchers from the Spanish National Cancer Centre (CNIO) showed unequivocally that increasing this enzyme in aging mice improves health and extends lifespan safely without any increase in rates of cancer. Continue reading




